HIV Drug Settlement Reached to Resolve Class Action Over Truvada, Stribild, Other Antiretrovirals
Bristol-Myers Squibb has agreed to pay $10 million to resolve its part in the class action lawsuit over HIV drugs with allegedly inflated prices.
January 03, 2022 By: Irvin Jackson
Bristol-Myers Squibb has agreed to pay $10 million to resolve its part in the class action lawsuit over HIV drugs with allegedly inflated prices.
Court has ordered parties to meet separately with a U.S. Magistrate Judge over the next two months, to discuss the best timing and structure for settlement negotiations to resolve Change Healthcare data breach lawsuits.
A group of plaintiffs have petitioned the U.S. Judicial Panel on Multidistrict Litigation to consolidate all Depo-Provera lawsuits before one federal judge for coordinated pretrial proceedings.
Lawsuit alleges a man suffered permanent hearing loss after several months of IV infusions of Tepezza, indicating that the drug maker delayed adding warnings to the thyroid eye disease drug label.
"*" indicates required fields